BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2953224)

  • 1. Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems.
    Manthey J; Osterziel KJ; Röhrig N; Dietz R; Hackenthal E; Schmidt-Gayk H; Kübler W
    Am J Cardiol; 1987 Apr; 59(10):171D-175D. PubMed ID: 2953224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril.
    de Graeff PA; Kingma JH; Dunselman PH; Wesseling H; Lie KI
    Am J Cardiol; 1987 Apr; 59(10):164D-170D. PubMed ID: 3034026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic effects of ramipril and captopril in congestive heart failure.
    de Graeff PA; Kingma JH; Viersma JW; Wesseling H; Lie KI
    Int J Cardiol; 1989 Apr; 23(1):59-67. PubMed ID: 2523870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic, hormonal and electrolyte effects of ramipril in severe congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    Am J Cardiol; 1987 Apr; 59(10):155D-163D. PubMed ID: 3034025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global and regional hemodynamic effects of ramipril in congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
    Witte PU; Walter U
    Am J Cardiol; 1987 Apr; 59(10):115D-120D. PubMed ID: 3034018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological effects of captopril and ramipril in patients with hypertension].
    Vil'chinskaia MIu; Nasonov EL; Zharova EA; Panfilov VV; Masenko VP; Oshchepkova EV; Beliakova EV
    Klin Med (Mosk); 1990 Feb; 68(2):61-4. PubMed ID: 2139910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of the new angiotensin converting enzyme inhibitor ramipril on hemodynamics and carotid sinus baroreflex activity in congestive heart failure.
    Vogt A; Unterberg C; Kreuzer H
    Am J Cardiol; 1987 Apr; 59(10):149D-154D. PubMed ID: 3034024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance of captopril-induced taste disturbance after substitution with angiotensin-converting-enzyme inhibitor HOE 498.
    Mauersberger H; Witte PU
    Lancet; 1985 Mar; 1(8427):517-8. PubMed ID: 2857878
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
    Riegger GA; Kochsiek K
    Am J Cardiol; 1986 Aug; 58(3):300-3. PubMed ID: 3526857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).
    Gerckens U; Grube E; Mengden T; Sigel H; Wagner WL; Lahn T; Irmisch R; Metzger H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S49-51. PubMed ID: 2474102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of ramipril.
    Ball SG; Robertson JI
    Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
    Schofer J; Hobuss M; Aschenberg W; Tews A
    Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
    Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
    J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
    Ferreira SR; Saragoça MA; Homsi E; Ajzen H; Draibe SA; Ribeiro AB; Ramos OL
    J Clin Hypertens; 1987 Dec; 3(4):685-94. PubMed ID: 3330991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.